Skip to Content

Blockchain-Based Medicine Verification System – Stakeholder Map

Central System (Core Enabler)

Verification System (Blockchain + QR Technology)
Role: Serves as the central trust and verification infrastructure that enables authentication of medicines across the healthcare supply chain.
Value Delivered: Transparency, accountability, counterfeit prevention, public health protection.

Primary Stakeholder Groups

1. Caretakers: Primary Guardians of Community Health

Healthcare Providers

Actors:

  • Community Health Workers

  • Nurses and Clinical Officers

  • Pharmacists

  • Traditional Healers

Role:
Frontline diagnosis, prescription, dispensing, and community health guidance.

Interaction with System:

  • Verify medicine authenticity before dispensing

  • Act as trusted intermediaries for patient adoption

Value Received:

  • Confidence in treatment efficacy

  • Reduced malpractice and reputational risk

  • Reinforced patient trust

Family Caregivers

Actors:

  • Parents

  • Adult children caring for elderly

  • Community volunteers

Role:
Primary decision-makers in medicine purchasing and administration.

Value Received:

  • Assurance of medicine safety

  • Reduced financial and health risks

  • Empowered purchasing decisions

2. Institutions & Local Actors

Government & Regulatory Bodies

Actors:

  • Rwanda FDA

  • Ministry of Health

  • Rwanda Biomedical Center

  • District Health Offices

Role:
Policy, regulation, enforcement, and system oversight.

Interaction with System:

  • Access audit trails and dashboards

  • Monitor market compliance and public health risks

Value Received:

  • Real-time oversight

  • Stronger regulatory enforcement

  • Evidence-based policymaking

Healthcare Facilities

Actors:

  • District hospitals

  • Health centers

  • Private clinics

  • Community pharmacies

Role:
Implementation sites and verification checkpoints.

Value Received:

  • Quality assurance

  • Reduced liability exposure

  • Enhanced institutional credibility

Supply Chain Actors

Actors:

  • Pharmaceutical manufacturers

  • Importers and distributors

  • Wholesalers

  • Logistics providers

Role:
Production, transportation, and distribution of medicines.

Interaction with System:

  • Record each handoff on blockchain

  • Authenticate batches and origin

Value Received:

  • Brand protection

  • Reduced counterfeit infiltration

  • Improved supply chain integrity

Technology & Innovation Ecosystem

Actors:

  • ICT Chamber Rwanda

  • Innovation hubs (K-Lab, Norrsken, FabLab)

  • Universities (UR, AUCA, CMU-Africa)

  • Blockchain communities

Role:
Technical development, research, and ecosystem support.

Value Received:

  • Innovation opportunities

  • Research and deployment partnerships

3. Emerging Leaders (Change Agents)

Youth Innovators

Actors:

  • Tech-savvy students

  • Young entrepreneurs

  • Digital health advocates

Role:
Solution development, advocacy, and early adoption.

Community Health Champions

Actors:

  • Patient advocates

  • Progressive pharmacy owners

  • Healthcare innovators

Role:
Trust-building and grassroots adoption.

Policy Entrepreneurs

Actors:

  • Health system reformers

  • Regulatory innovators

  • PPP facilitators

Role:
Policy modernization and partnership creation.

4. Groups Most Affected by the Challenge

High-Risk Populations

Actors:

  • Children under 5

  • Chronic disease patients

  • HIV/AIDS patients

  • Pregnant women

Impact:
Severe health consequences from counterfeit medications.

Economically Vulnerable Groups

Actors:

  • Low-income families

  • Rural communities

  • Informal sector workers

Impact:
Disproportionate financial and health burden.

Trust-Affected Groups

Actors:

  • Skeptical patients

  • Victims of counterfeit medicines

  • Families of deceased patients

Impact:
Healthcare avoidance and systemic distrust.

Business Stakeholders

Actors:

  • Legitimate manufacturers

  • Ethical distributors

  • Pharmacy owners

  • Healthcare facilities

Impact:
Revenue loss, reputational damage, legal exposure.

Stakeholder Relationship Flow

Government & Regulators (Policy & Oversight)
↓
Manufacturers → Distributors → Pharmacies → Patients
↓
Blockchain Verification System
↓
Outcomes: Transparency → Accountability → Trust → Empowerment

Stakeholder Power: Interest Overview

  • High Power / High Interest: Regulators, major distributors, large pharmacy chains

  • High Power / Low Interest: International pharma firms, development partners

  • Low Power / High Interest: Patients, CHWs, small pharmacies

  • Low Power / Low Interest: General public, peripheral actors

Last updated on
Submission Guidelines